Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Kristiina Vuori, M.D., Ph.D., is a distinguished physician-scientist serving as the President and CEO of the Sanford Burnham Prebys Medical Discovery Institute (SBP). She also holds the Pauline & Stanley Foster Presidential Chair at SBP. Dr. Vuori's research has significantly contributed to understanding the molecular mechanisms of cancer, particularly focusing on cell adhesion, integrin signaling, and cancer metastasis. Her laboratory investigates how cancer cells survive, invade, and spread to distant organs. In her leadership role, Dr. Vuori guides SBP's strategic direction, fostering a collaborative and innovative research environment aimed at accelerating the translation of basic scientific discoveries into novel therapies for human diseases, including cancer, neurodegenerative diseases, and infectious diseases. She is deeply committed to advancing biomedical research and improving patient outcomes through scientific excellence and innovation.
Kristiina Vuori's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Leads one of the top independent, non-profit biomedical research institutes in the United States, guiding its scientific vision, strategic partnerships, and efforts to translate discoveries into life-changing treatments.
Her laboratory has made significant discoveries in understanding the molecular pathways, particularly involving integrins and cell adhesion molecules, that drive cancer cell invasion, survival, and metastasis, which is the primary cause of cancer-related deaths.
Successfully secured substantial research funding from prestigious organizations like the National Institutes of Health (NIH) and the Department of Defense (DoD), reflecting the high impact and quality of her research.
Serves on various national and international scientific advisory boards, committees, and review panels, contributing to shaping research priorities and policies. She is also an elected member of the National Academy of Medicine.
Actively promotes the translation of basic research findings into clinical applications, fostering collaborations between academia, industry, and philanthropic organizations to accelerate the development of new therapies.
University of Helsinki
University of Oulu
University of Oulu
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Sanford Laboratories for Innovative Medicines, part of Sanford Research and Sanford Health, is a specialized research group dedicated to accelerating the discovery and development of novel therapeutics. They focus particularly on rare diseases and conditions with significant unmet medical needs, aiming to bridge the gap between basic scientific discoveries and clinical applications. Their work often involves advanced drug screening, preclinical modeling, and translational research to bring potential treatments to patients faster.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.